While VCR struggles through the trial stage the market matures with well established major products like Novacor's Heartmate and the star Abiomed which even has a total replacement heart.
Remember that VCR has one unlicensed left ventricle assist device while there are installed and licensed biventricular devices saving lives.
Sort of like inventing an Australian backyard car to take on Ford.
Here's the Abiomed latest:
DANVERS, Mass., Dec. 09 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (Nasdaq: ABMD - News) a manufacturer of products for circulatory care and support, today announced the launch of a new education and service program designed to promote heart recovery. The program combines clinical training, web-based education, process improvement, and field service.
"By providing clinical support and education on best practices including early implantation, time on support, and reducing bleeding, we can help our hospitals improve outcomes," said Michael R. Minogue, CEO and President of ABIOMED. "Our goal is to give our customers the tools they need to help acute patients recover and go home with their own hearts."
The program includes web-based learning module developed by eTrinsic that will enable clinical teams to be trained on the AB5000 and BVS 5000 using an interactive course that simulates the clinical experience. The course will also share the techniques and practices that have been shown to promote survival and recovery at ABIOMED's top centers. For instance, at the top 20% of centers in the company's installed base, the survival rate for patients implanted with ABIOMED's Ventricular Assist Devices (VADs) is greater than 50%.(1)
The courses are accredited and healthcare providers that successfully complete the modules are eligible to receive continuing education credits. Additional clinical modules on ABIOMED's products and a general program designed to educate patients and families will be available in the near future.
In addition, ABIOMED is offering its service program customers an on-site productivity and best practices consult, a reimbursement kit, and a media and marketing kit. The media and marketing kit will provide hospitals with the tools necessary to educate audiences including referring cardiologists, VAD coordinators, patients, families, and health reporters on the addition of this life-saving technology. The Best Practices consult will include an analysis of both clinical and administrative practices, and offer solutions to optimize reimbursement, improve processes and enhance patient outcomes.
About ABIOMED
Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced "AB'-EE-O-MED") is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart. ABIOMED, which currently sells the BVS® 5000 Biventricular Support System and the AB5000(TM) Circulatory Support System, is the market leader in devices for the temporary support of patients with failing but potentially recoverable hearts. In September 2004, ABIOMED applied for initial FDA market approval for the AbioCor Implantable Replacement Heart to treat a defined subset of irreversible end-stage heart failure patients under a Humanitarian Device Exemption.
VCR
ventracor limited
